Clarity Pharmaceuticals Statistics
Total Valuation
CLRPF has a market cap or net worth of 1.07 billion. The enterprise value is 998.62 million.
| Market Cap | 1.07B |
| Enterprise Value | 998.62M |
Important Dates
The next estimated earnings date is Friday, August 22, 2025.
| Earnings Date | Aug 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 371.89M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +15.21% |
| Shares Change (QoQ) | +11.53% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 274.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 160.49 |
| PB Ratio | 13.58 |
| P/TBV Ratio | 13.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -33.13 |
| EV / Sales | 143.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -34.33 |
Financial Position
The company has a current ratio of 14.55
| Current Ratio | 14.55 |
| Quick Ratio | 13.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.99% and return on invested capital (ROIC) is -39.07%.
| Return on Equity (ROE) | -53.99% |
| Return on Assets (ROA) | -36.11% |
| Return on Invested Capital (ROIC) | -39.07% |
| Return on Capital Employed (ROCE) | -44.17% |
| Revenue Per Employee | 133,385 |
| Profits Per Employee | -602,801 |
| Employee Count | 50 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CLRPF has paid 146,323 in taxes.
| Income Tax | 146,323 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.68% in the last 52 weeks. The beta is 1.63, so CLRPF's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -33.68% |
| 50-Day Moving Average | 1.86 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 73.94 |
| Average Volume (20 Days) | 5,163 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CLRPF had revenue of 6.67 million and -30.14 million in losses. Loss per share was -0.10.
| Revenue | 6.67M |
| Gross Profit | 6.67M |
| Operating Income | -34.90M |
| Pretax Income | -29.99M |
| Net Income | -30.14M |
| EBITDA | -34.78M |
| EBIT | -34.90M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 68.81 million in cash and n/a in debt, giving a net cash position of 68.81 million.
| Cash & Cash Equivalents | 68.81M |
| Total Debt | n/a |
| Net Cash | 68.81M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 78.81M |
| Book Value Per Share | 0.25 |
| Working Capital | 78.66M |
Cash Flow
In the last 12 months, operating cash flow was -28.99 million and capital expenditures -103,109, giving a free cash flow of -29.09 million.
| Operating Cash Flow | -28.99M |
| Capital Expenditures | -103,109 |
| Free Cash Flow | -29.09M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -523.30% |
| Pretax Margin | -449.73% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLRPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.21% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.82% |
| FCF Yield | -2.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CLRPF has an Altman Z-Score of 92.26 and a Piotroski F-Score of 2.
| Altman Z-Score | 92.26 |
| Piotroski F-Score | 2 |